A rapid diagnostic technology developed by BioEclosion and the Universitat Autònoma de Barcelona (UAB) has been assessed by the European Commission’s Innovation Radar and classified as “Market Ready”, with “Market Read More
A rapid diagnostic technology developed by BioEclosion and the Universitat Autònoma de Barcelona (UAB) has been assessed by the European Commission’s Innovation Radar and classified as “Market Ready”, with “Market Read More